| Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies (NCT06772090) | Masonic Cancer Center, University of Minnesota | 2026-12-25 |
| GutCheck: Optimization of a Personalized Mobile Health App for Survivors of Gastrointestinal Cancer (NCT07661017) | Masonic Cancer Center, University of Minnesota | 2026-12-01 |
| BAriaTric Surgery After Breast Cancer Treatment (BATS) (NCT03946423) | Masonic Cancer Center, University of Minnesota | 2026-06-01 |
| Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT (NCT07591649) | Masonic Cancer Center, University of Minnesota | 2026-05-08 |
| First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma (NCT07560865) | Masonic Cancer Center, University of Minnesota | 2026-04-23 |
| MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases (NCT07493538) | Masonic Cancer Center, University of Minnesota | 2026-04-10 |
| Rural Smoking Cessation (NCT06584929) | Masonic Cancer Center, University of Minnesota | 2026-03-17 |
| LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer (NCT07153016) | Masonic Cancer Center, University of Minnesota | 2025-09-09 |
| HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL (NCT06792825) | Masonic Cancer Center, University of Minnesota | 2025-08-07 |
| UNTOLD Ovarian Cancer Unmet Needs Survey (NCT07070726) | Masonic Cancer Center, University of Minnesota | 2025-07-10 |
| Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML) (NCT07008638) | Masonic Cancer Center, University of Minnesota | 2025-07-07 |
| American Indian Smokefree Native RCT (NCT06544811) | Masonic Cancer Center, University of Minnesota | 2025-04-14 |
| Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise (NCT05025774) | Masonic Cancer Center, University of Minnesota | 2025-03-14 |
| Adenovirus (RGDCRAdCOX2F) (NCT06693986) | Masonic Cancer Center, University of Minnesota | 2024-12-27 |
| MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma (NCT06377540) | Masonic Cancer Center, University of Minnesota | 2024-12-04 |
| HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML (NCT06594445) | Masonic Cancer Center, University of Minnesota | 2024-11-19 |
| Allo HSCT for High Risk Hemoglobinopathies (NCT06872333) | Masonic Cancer Center, University of Minnesota | 2024-11-19 |
| Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures (NCT06295757) | Masonic Cancer Center, University of Minnesota | 2024-10-12 |
| Remote Trial - Tobacco Product Standard (VLNC) (NCT06442384) | Masonic Cancer Center, University of Minnesota | 2024-09-11 |
| Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia (NCT05700630) | Masonic Cancer Center, University of Minnesota | 2024-07-15 |
| Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT06342986) | Masonic Cancer Center, University of Minnesota | 2024-07-11 |
| A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma (NCT04629209) | Masonic Cancer Center, University of Minnesota | 2024-06-28 |
| Effect of Kava on Anxiety and Stress in Cancer Survivors (NCT06213298) | Masonic Cancer Center, University of Minnesota | 2024-06-20 |
| MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. (NCT06412497) | Masonic Cancer Center, University of Minnesota | 2024-06-05 |
| Feasibility Study - Filter Ventilation (NCT04514471) | Masonic Cancer Center, University of Minnesota | 2024-03-18 |
| Assessing the Time Demands of Cancer (NCT05708703) | Masonic Cancer Center, University of Minnesota | 2023-11-13 |
| Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy (NCT06411795) | Masonic Cancer Center, University of Minnesota | 2023-11-10 |
| MT2022-01: MSCs for ALD (NCT06030648) | Masonic Cancer Center, University of Minnesota | 2023-08-28 |
| Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors (NCT05665543) | Masonic Cancer Center, University of Minnesota | 2023-07-24 |
| Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids (NCT05123040) | Masonic Cancer Center, University of Minnesota | 2023-06-05 |
| Study of PAT in Patients With Solid Tumor Cancers (NCT05338658) | Masonic Cancer Center, University of Minnesota | 2023-05-19 |
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies (NCT05735717) | Masonic Cancer Center, University of Minnesota | 2023-05-11 |
| Allo HSCT Using RIC and PTCy for Hematological Diseases (NCT05805605) | Masonic Cancer Center, University of Minnesota | 2023-05-01 |
| MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT05708924) | Masonic Cancer Center, University of Minnesota | 2023-04-28 |
| Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) (NCT05705700) | Masonic Cancer Center, University of Minnesota | 2023-02-01 |
| QuitGuide for American Indians: Aims 2 & 3 (NCT05447156) | Masonic Cancer Center, University of Minnesota | 2022-12-14 |
| RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial (NCT04105270) | Masonic Cancer Center, University of Minnesota | 2022-11-30 |
| Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH. (NCT05634512) | Masonic Cancer Center, University of Minnesota | 2022-11-17 |
| App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer (NCT05502302) | Masonic Cancer Center, University of Minnesota | 2022-07-28 |
| Role of Acetaldehyde in the Development of Oral Cancer (NCT05973656) | Masonic Cancer Center, University of Minnesota | 2022-07-08 |
| NF-1, Nutraceutical Intervention (NCT05363267) | Masonic Cancer Center, University of Minnesota | 2022-07-06 |
| Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users (NCT04003805) | Masonic Cancer Center, University of Minnesota | 2022-05-11 |
| Diagnosis and Treatment of Periodontal Disease in Patients With AML (NCT04530695) | Masonic Cancer Center, University of Minnesota | 2022-05-01 |
| HCW9218 in Select Advanced Solid Tumors (NCT05322408) | Masonic Cancer Center, University of Minnesota | 2022-04-01 |
| PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation (NCT05120570) | Masonic Cancer Center, University of Minnesota | 2022-03-17 |
| Sugars in Cigarettes (NCT05308316) | Masonic Cancer Center, University of Minnesota | 2022-02-24 |
| Charcoal in Lung Cancer Patients Undergoing TEMLA (NCT04928950) | Masonic Cancer Center, University of Minnesota | 2022-01-26 |
| FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia (NCT04714372) | Masonic Cancer Center, University of Minnesota | 2021-11-03 |
| Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL (NCT04855253) | Masonic Cancer Center, University of Minnesota | 2021-06-09 |
| Telehealth-Filter Ventilation ( COMET2P1 ) (NCT04969783) | Masonic Cancer Center, University of Minnesota | 2021-05-26 |
| Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy (NCT04858594) | Masonic Cancer Center, University of Minnesota | 2021-05-04 |
| Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices (NCT04740008) | Masonic Cancer Center, University of Minnesota | 2021-04-20 |
| FT516 and IL2 With Enoblituzumab for Ovarian Cancer (NCT04630769) | Masonic Cancer Center, University of Minnesota | 2021-04-02 |
| Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens (NCT03978117) | Masonic Cancer Center, University of Minnesota | 2021-02-18 |
| FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL (NCT04555811) | Masonic Cancer Center, University of Minnesota | 2020-09-22 |
| Metabolism of NNK in Japanese Americans (NCT04228952) | Masonic Cancer Center, University of Minnesota | 2020-09-01 |
| Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel (NCT04514029) | Masonic Cancer Center, University of Minnesota | 2020-08-06 |
| Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) (NCT04466098) | Masonic Cancer Center, University of Minnesota | 2020-07-30 |
| Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia (NCT04363346) | Masonic Cancer Center, University of Minnesota | 2020-05-14 |
| Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS (NCT04055844) | Masonic Cancer Center, University of Minnesota | 2020-02-17 |
| Observational Study of Exposure to Environmental Toxicants Among Firefighters (NCT05643014) | Masonic Cancer Center, University of Minnesota | 2020-02-01 |
| A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers (NCT04204772) | Masonic Cancer Center, University of Minnesota | 2020-01-22 |
| CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone (NCT03934840) | Masonic Cancer Center, University of Minnesota | 2019-10-10 |
| A Study of FMT in Patients With AML Allo HSCT in Recipients (NCT03678493) | Masonic Cancer Center, University of Minnesota | 2019-09-09 |
| Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer (NCT03981705) | Masonic Cancer Center, University of Minnesota | 2019-08-08 |
| Radiation and Combination Immunotherapy for Melanoma (NCT03850691) | Masonic Cancer Center, University of Minnesota | 2019-05-28 |
| Adrenoleukodystrophy National Registry Study (NCT03789721) | Masonic Cancer Center, University of Minnesota | 2019-05-01 |
| Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy (NCT03674411) | Masonic Cancer Center, University of Minnesota | 2019-01-02 |
| MT2017-45: CAR-T Cell Therapy for Heme Malignancies (NCT03642626) | Masonic Cancer Center, University of Minnesota | 2018-12-18 |
| Study of CD133KDEL Toxin in the Treatment for Solid Tumors (NCT02845414) | Masonic Cancer Center, University of Minnesota | 2018-12-01 |
| Trial of Indole-3-Carbinol and Silibinin (NCT03687073) | Masonic Cancer Center, University of Minnesota | 2018-11-29 |
| CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig (NCT03383055) | Masonic Cancer Center, University of Minnesota | 2018-11-16 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders (NCT03579875) | Masonic Cancer Center, University of Minnesota | 2018-11-13 |
| Early Diagnosis Of Childhood Cerebral ALD (NCT02948062) | Masonic Cancer Center, University of Minnesota | 2018-11-01 |
| QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML (NCT03365661) | Masonic Cancer Center, University of Minnesota | 2018-10-30 |
| COMET2 Project 1 Filter Ventilation Study (NCT03637972) | Masonic Cancer Center, University of Minnesota | 2018-10-18 |
| Exemestane in Post-Menopausal Women With NSCLC (NCT02666105) | Masonic Cancer Center, University of Minnesota | 2018-09-27 |
| Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies (NCT03557749) | Masonic Cancer Center, University of Minnesota | 2018-09-21 |
| Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training (NCT03609203) | Masonic Cancer Center, University of Minnesota | 2018-09-10 |
| Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS (NCT03417154) | Masonic Cancer Center, University of Minnesota | 2018-08-13 |
| Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases (NCT03367546) | Masonic Cancer Center, University of Minnesota | 2018-07-02 |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders (NCT03314974) | Masonic Cancer Center, University of Minnesota | 2018-03-30 |
| Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma (NCT03297463) | Masonic Cancer Center, University of Minnesota | 2018-01-31 |
| BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy (NCT03294304) | Masonic Cancer Center, University of Minnesota | 2018-01-29 |
| Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy (NCT03728699) | Masonic Cancer Center, University of Minnesota | 2018-01-02 |
| Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) (NCT04225572) | Masonic Cancer Center, University of Minnesota | 2017-12-27 |
| Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int (NCT03213964) | Masonic Cancer Center, University of Minnesota | 2017-10-19 |
| Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL (NCT03019666) | Masonic Cancer Center, University of Minnesota | 2017-10-18 |
| IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer (NCT03054909) | Masonic Cancer Center, University of Minnesota | 2017-09-19 |